Antibiotic resistance in gonorrhea Antibiotic resistance in gonorrhea The Gonorrhea bacterium Neisseria gonorrhoeae has developed antibiotic resistance to many antibiotics. The bacteria was first identified in 1879, although some Biblical scholars believe that references to the disease can be found as early as Parshat Metzora of the Old Testament. In the 1940s effective treatment with penicillin became available, but by the 1970s resistant strains predominated. Resistance to penicillin has developed through two mechanisms: chromasomally mediated resistance (CMRNG) and penicillinase-mediated resistance (PPNG). CMRNG involves step wise mutation of penA, which codes for the penicillin-binding protein (PBP-2); mtr, which encodes an efflux pump that removes penicillin
Antibiotic-Antimycotic reproductive techniques. In animal cell culture, Antibiotic-Antimycotic solution was used to wash goat embryos prior to incubation with oviduct and uterine cells, for enhanced development of embryos into blastocysts. In large-scale bioreactors, contamination risk is high due to the connection of tubing from inlets and outlets. Antibiotic-Antimycotic solution was incorporated into media for culturing suspension-adapted human embryonic kidney (HEK) 293 cell lines in bioreactors. The ability to isolate cell types is an important component of tissue engineering. In order to prevent contamination during seeding of human fibroblasts followed by endothelial cells on polymeric scaffolds, Antibiotic-Antimycotic solution was used during the